Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 Cyano 3 Hydroxybutyrate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101260415A reveals high-efficiency biocatalytic route for chiral intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101260415A reveals biocatalytic route for chiral intermediates. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Advanced synthesis of Ethyl (R)-4-Cyano-3-Hydroxybutyrate via epoxide intermediate. High purity >99%, scalable process for Atorvastatin manufacturing.
Patent CN103420870A details a novel carbonylation route for high-purity chiral 4-cyano-3-hydroxybutyrate, offering significant cost reduction and scalable manufacturing for statin intermediates.
Advanced Salen-catalyzed kinetic resolution process for high-purity statin intermediates. Delivers cost reduction in API manufacturing and reliable supply chain continuity.